Methods for predicting therapeutic response to agents acting on the growth hormone receptor
CA 2510045 A1 · Owner: Pharmacia Ab · Inventors: Bougneres, Pierre
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods of producing a subject~s response to an agent capable of binding to a growth hormone receptor (GHR) protein comprise determining in the subject the presence or absence of an allele of the (GHR) gene wherein the allele is , coordinated with the likelihood of having an increased or decreased positive response to the agent, thereby identifying the subject as having an increased or decreased likelihood of responding to treatment with the agent.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 10, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 10, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 10, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.